Literature DB >> 17984310

Daily cyclophosphamide for scleroderma: are patients with the most to gain underrepresented in this trial?

Athol U Wells, Panagiota Latsi, W Joseph McCune.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17984310     DOI： 10.1164/rccm.200708-1185ED

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN： 1073-449X            Impact factor:   21.405


× No keyword cloud information.
  4 in total

Review 1.  Management of interstitial lung disease associated with connective tissue disease.

Authors:  Stephen C Mathai; Sonye K Danoff
Journal:  BMJ       Date:  2016-02-24

Review 2.  Scleroderma lung disease.

Authors:  Joshua J Solomon; Amy L Olson; Aryeh Fischer; Todd Bull; Kevin K Brown; Ganesh Raghu
Journal:  Eur Respir Rev       Date:  2013-03-01

3.  Rapidly progressive fatal interstitial lung disease in a patient with systemic sclerosis.

Authors:  Kristine Phillips; Cathryn Byrne-Dugan; Eric Batterson; James R Seibold
Journal:  Nat Rev Rheumatol       Date:  2009-04       Impact factor: 20.543

Review 4.  Recent Treatments of Interstitial Lung Disease with Systemic Sclerosis.

Authors:  Hidekata Yasuoka
Journal:  Clin Med Insights Circ Respir Pulm Med       Date:  2016-01-19
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.